KT Squared LLC

About

Portfolio · 4

Novidea Software

Cloud-based Insurance Solutions

5 rounds $118.0M committed Latest: 2024-04

EGM

Electrical Grid Monitoring and Managing Tool

1 round $17.0M committed Latest: 2022-01

GaitBetter

Motor-Cognitive Gait Training & Fall Prevention

Led ★ 1 round $1.1M committed Latest: 2020-05

Neurolief

Brain Neuromodulation Technology

1 round $4.8M committed Latest: 2017-06

Investment activity

Q&A

What is KT Squared LLC's investment focus?

Founded in 2016, KT Squared LLC invests in Israeli startups with strong innovative leadership and mature technology or products nearing commercialization. Their investments span sectors such as biotech, mobile retailing, fleet management, fintech, and energy.

Which sectors has KT Squared LLC concentrated its investments in?

KT Squared LLC has concentrated its investments in Fintech & Insurtech, Health Tech & Life Sciences, and Energy Tech.

Can you name some notable portfolio companies for KT Squared LLC?

Notable portfolio companies for KT Squared LLC include Novidea Software, which provides cloud-based insurance solutions, and Neurolief, focused on brain neuromodulation technology.

What was KT Squared LLC's most recent investment activity?

KT Squared LLC participated in an investment round in April 2024.

What is the total amount KT Squared LLC has invested in Israeli startups?

KT Squared LLC has invested over $40 million in Israeli startups since its founding in 2016.

What is the typical investment range for KT Squared LLC?

KT Squared LLC typically invests between $1.1 million and $50 million per deal.

Has KT Squared LLC made any recent investments in the Health Tech & Life Sciences sector?

Yes, KT Squared LLC has invested in companies like GaitBetter, which focuses on motor-cognitive gait training and fall prevention, and Neurolief, a brain neuromodulation technology company.

When did KT Squared LLC make its most recent new portfolio company investment?

KT Squared LLC made its most recent new portfolio company investment in January 2022.